InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by OMSTEAD DANIEL R, Président. Director active across 1 companies, notably Tekla Life Sciences Investors. In total, 2 reports have been published. Total volume traded: €236k. The latest transaction was filed on 11 August 2021 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€117,9516,403 shares@ €18.4212100.0% of flow
Shares of Beneficial Interest
SEC:0001104659-21-103959·
Ideal exit: 8 May 2022 (T+270)
€117,9516,403 shares@ €18.42120.026% mcap50.0% of flow
Shares of Beneficial Interest
SEC:0001104659-21-103959:0·
Ideal exit: 8 May 2022 (T+270)
2 of 2 declarations
About OMSTEAD DANIEL R
Daniel R. Omstead is the President of Tekla Life Sciences Investors. He is responsible for managing and directing investments in the life sciences sector. His investment expertise is essential for maximizing the performance of Tekla's portfolio.
